Articles with public access mandates - Shahid Khan - Health Data Research, UKLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallNIHWellcomeMRCNIHRGatesDOESNSFEuropean CommissionUK Research & InnovationNWOFCTVersus Arthritis, UKCancer Research UKHealth Data Research, UKHHMICIHRDSTNHMRCFWONSERCNERCZonMwARCNSFCDFGINSERMHRBBBSRCBHFNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKProstate Cancer UKWHOGovernment of SpainDamon Runyon Cancer Research FoundationRoyal Society UKHFSPMedical Research Future Fund, Australia
Not available based on mandate: 3
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 399 (10325), 665-676, 2022
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 401 (10387), 1499-1507, 2023
Available based on mandate: 1
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023
Publication and funding information is determined automatically by a computer program